Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

Stock Information for NovaBay Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
NioBay Presents Its 2024 Year End Report
NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
NioBay Announces a New Member to Its Board of Directors
NioBay Announces Closing of a Private Placement

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.